Responses
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0168 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BI 655064, An Antagonistic Anti-CD40 Antibody in Healthy Volunteers
Compose a Response to This Article
Other responses
No responses have been published for this article.